Skip to main content

Treating Slow-Growing Non-Hodgkin Lymphomas (NHL)

May 4, 2021

Topics Covered

We invite you to learn more about:

  • Slow-growing non-Hodgkin lymphomas (NHL)
  • Treatment advances for slow-growing lymphomas
  • Side-effects management
  • Ways to effectively communicate with your healthcare team about quality-of-life issues

Program Materials


Matthew S. McKinney, MD
Duke University School of Medicine
Department of Medicine
Division of Hematologic Malignancies
Durham, NC

Program Support

Support for this program is provided by Bristol Myers Squibb; Epizyme, Inc.; Genentech, Inc. & Biogen and Pharmacyclics, An AbbVie Company & Janssen Biotech.


< Back to Webcasts